4basebio: Heikki Lanckriet, David Roth

Heikki Lanckriet and David Roth have resigned from the management board of German company 4basebio (formerly Expedeon). Going forward, they will focus on managing the operational business of the company's UK spinoff, 4basebio SE, which plans to start trading on the Alternative Investment Market (AIM), a market segment of the London Stock Exchange, in January.